Menu Search
Equities

Metropolis Healthcare Ltd

METROPOLIS:NSI

Metropolis Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2,032.20
  • Today's Change-12.80 / -0.63%
  • Shares traded99.06k
  • 1 Year change+26.15%
  • Beta0.6964
Data delayed at least 15 minutes, as of Nov 14 2024 10:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Metropolis Healthcare Ltd had net income fall -10.54% from 1.43bn to 1.28bn despite a 5.18% increase in revenues from 11.48bn to 12.08bn. An increase in the selling, general and administrative costs as a percentage of sales from 50.10% to 52.76% was a component in the falling net income despite rising revenues.
Gross margin78.91%
Net profit margin11.56%
Operating margin16.32%
Return on assets9.47%
Return on equity13.27%
Return on investment11.23%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Metropolis Healthcare Ltd fell by 62.15m. However, the company earned 2.64bn from its operations for a Cash Flow Margin of 21.82%. In addition the company used 894.12m on investing activities and also paid 1.81bn in financing cash flows.
Cash flow per share49.06
Price/Cash flow per share41.64
Book value per share231.05
Tangible book value per share67.72
More ▼

Balance sheet in INRView more

Metropolis Healthcare Ltd has a Debt to Total Capital ratio of 13.76%, a higher figure than the previous year's 11.39%.
Current ratio1.64
Quick ratio1.49
Total debt/total equity0.16
Total debt/total capital0.1376
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items dropped -10.59%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)0.7017
EPS (TTM) vs
TTM 1 year ago		10.68
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.